Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-10-8
|
pubmed:abstractText |
So far, the physiological role of insulin-like growth factor binding protein-2 (IGFBP-2) has not been demonstrated directly. Therefore, we transfected 293 cells with an expression vector containing the CMV promoter and the complete cDNA of mouse IGFBP-2. Secretion of bioactive IGFBP-2 into conditioned medium was demonstrated by Western ligand and Western immunoblotting and quantified by specific RIA. For the analysis of cell proliferation three clones exhibiting either high or low/no IGFBP-2 expression were selected and compared to non-transfected parental 293 cells. IGFBP-2 secreting clones displayed reduced conversion of thiazolyl blue when compared to negative clones or non-transfected parental 293 cells (P < 0.01). The lower growth activity measured in the IGFBP-2 secreting clones was compensated in great part by the administration of exogenous IGF-I or -II. Conditioned media of IGFBP-2 secreting clones inhibited growth of IGF-responsive colon tumor cell lines (LS513, HT-29) while those of negative clones did not. In addition, conditioned medium from a clone expressing high levels of IGFBP-2 inhibited anchorage-independent growth of LS513 and HT-29 cells. In contrast, growth of an IGF-unresponsive tumor cell line (Co-115) was not affected by the conditioned media. We hypothesize that IGFBP-2 might sequester the IGFs and thus prevent them from transferring their mitogenic signals.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
434
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-34
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9742949-Animals,
pubmed-meshheading:9742949-Cell Adhesion,
pubmed-meshheading:9742949-Cell Division,
pubmed-meshheading:9742949-Cell Line,
pubmed-meshheading:9742949-Clone Cells,
pubmed-meshheading:9742949-Colonic Neoplasms,
pubmed-meshheading:9742949-Culture Media, Conditioned,
pubmed-meshheading:9742949-Fibroblasts,
pubmed-meshheading:9742949-Humans,
pubmed-meshheading:9742949-Insulin-Like Growth Factor Binding Protein 2,
pubmed-meshheading:9742949-Kidney,
pubmed-meshheading:9742949-Mice,
pubmed-meshheading:9742949-RNA, Messenger,
pubmed-meshheading:9742949-Somatomedins,
pubmed-meshheading:9742949-Transfection,
pubmed-meshheading:9742949-Tumor Cells, Cultured
|
pubmed:year |
1998
|
pubmed:articleTitle |
Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines.
|
pubmed:affiliation |
Lehrstuhl für Molekulare Tierzucht und Haustiergenetik/Genzentrum, Ludwig-Maximilians-Universität, Munich, Germany. hoeflich@lmb.uni-muenchen.de
|
pubmed:publicationType |
Journal Article
|